Table 4.
Use of rescue medication
| Subjects receiving rescue medications, n (%) | FAST-1 | FAST-2 | FAST-3 (nonlaryngeal population) | ||||
|---|---|---|---|---|---|---|---|
|
|
|
|
|||||
| Icatibant (n = 27) | Placebo (n = 29) | Icatibant (n = 36) | Tranexamic acid (n = 38) | Icatibant (n = 43) | Placebo (n = 45) | P value | |
| In the first 12 h | 3 (11) | 13 (45) | 0 | 5 (13) | |||
| In the first 48 h | 6 (22) | 15 (52) | 6 (17) | 11 (29) | |||
| Before 50% reduction in symptom severity | 0 | 16 (36) | <0.001 | ||||
| At any time during the attack and up to 5 days | 3 (7) | 18 (40) | <0.001 | ||||
Note: Values are expressed as number (%).